HUNTSMAN RONALD KIRK (Chairman & CEO) purchased 90.9% of their position (5K shares) of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $15.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/18/2021ACC: 0001493152-21-020536
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
+5K
Net shares
Net buyer
$15.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$3.00
Trade value
$15K
% of position
90.9%
8/17/2021
5.50K→10.50K
Total
Net shares
+5K
Net value
$15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2021 | P · Purchase | +5K | $3.00 | $15K | 90.9% | 5.50K | 10.50K |
| Total | +5K | $15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74M
Total
1.74M indirect1.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74M | Indirect |
| Total | 1.74M | 1.74M indirect |
Derivative Holdings (Post-Transaction)1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
333.33K
Shares owned
333.33K
Exercise price
1.65
Expiration
—
Exercise window
—
Total
Underlying
333.33K
Owned
333.33K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.65 | — | — | 333.33K | 333.33K |
| Total | 333.33K | 333.33K | ||||